Home Blog Page 4

Four Democrat Mayors Called Before Congress to Face Grilling Over ‘Sanctuary Cities’

The Democratic mayors of four major liberal cities are being called to Congress to testify for running their “sanctuary cities” policies.

The House Oversight Committee recently sent out letters to the four mayors.

“The Committee on Oversight and Government Reform is investigating sanctuary jurisdictions across the United States and their impact on public safety and the effectiveness of federal efforts to enforce the immigration laws of the United States. Sanctuary jurisdictions and their misguided and obstructionist policies hinder the ability of federal law enforcement officers to effectuate safe arrests and remove dangerous criminals from American communities, making Americans less safe,” wrote Chairman Comer.

Comer stated that “Boston, Chicago, Denver, and New York City are sanctuary jurisdictions that refuse to fully cooperate with federal immigration enforcement.”

He added that such sanctuary jurisdictions are “states, counties or cities that put some limits on how much they are willing to cooperate with federal agencies’ efforts to deport” illegal aliens.

“These jurisdictions take it upon themselves to decide what laws they will and will not abide by all for the purpose of shielding removable aliens, especially criminals, from federal law enforcement,” he continued, noting, “There are about 12 states and hundreds of cities and counties with sanctuary laws or policies across the country.”

“On the first day of his second term, President Donald Trump took decisive actions to restore the rule of law with respect to immigration enforcement,” Chairman Comer explained. “In addition to the efforts of the Trump Administration to ensure federal immigration enforcement can proceed unimpeded, Congress must determine whether further legislation is necessary to enhance border security and public safety. It is imperative that federal immigration law is enforced and that criminal aliens are swiftly removed from our communities.”

Chicago Mayor Brandon Johnson was one of the mayors to be called to testify before Congress, as noted by Fox 32.

Chicago Mayor Brandon Johnson remains firm in his support for the city’s sanctuary status, despite mounting pressure from the White House and national polls indicating that most Americans favor stricter immigration enforcement. His stance has frustrated some moderate members of the Chicago City Council, who have voiced concerns over the policy’s impact on city resources and public sentiment.

The debate over Chicago’s sanctuary law has intensified as the city continues to grapple with an influx of migrants, straining shelters and social services. While Johnson has defended the policy as a commitment to protecting immigrant rights, critics argue that it places an undue burden on local taxpayers and law enforcement.

The internal divisions within Chicago’s leadership reflect broader national tensions over immigration policy, with some council members pushing for reconsideration of the sanctuary law. However, Johnson has shown no signs of backing down, maintaining that Chicago will remain a welcoming city for all, regardless of federal pressure.

“The liberals control everything,” Chicago Alderman Nicholas Sposato said. “So if they want to remain a sanctuary city and protect criminals over law-abiding citizens in our community then I guess that’s the way it’s going to be.”

Alderman Nicholas Sposato was one of just 11 Chicago aldermen who voted in January to amend the city’s Welcoming City Ordinance (WCO), which prohibits local authorities from cooperating with Immigration and Customs Enforcement (ICE). The proposed amendment sought to allow cooperation in cases where an illegal migrant was wanted for serious criminal offenses.

However, the measure was overwhelmingly rejected by the City Council’s left-wing majority in a 39-11 vote. Alderman Raymond Lopez, who introduced the amendment alongside another Democrat, condemned the decision, arguing that the current policy protects dangerous criminals.

“It shouldn’t take an act of Congress or City Council, for that matter, to say we’re not going to protect child sexual predators and human traffickers,” Lopez remarked. “But yet, that’s exactly what the City Council did when it rejected the amendment that would allow our police officers to work with federal partners when someone is arrested or convicted of four very specific violent and dangerous crimes.”

The amendment specifically targeted illegal migrants arrested or convicted of:

  • Sexual crimes against minors
  • Gang-related activities
  • Drug-related offenses
  • Prostitution-related crimes

Lopez criticized the city’s stance, saying some of his colleagues dismissed ICE cooperation altogether. “My colleagues have said, ‘If ICE wants them, ICE can go get them in the neighborhoods themselves. We’re not going to help,’” he said. “Well, who does that really help?”

Rep. Delia Ramirez recently addressed a Chicago crowed and vowed resistance to Trump’s deportation policies.

“We have shown them that we are courageous,” Ramirez said. “We have shown them that we are organized. And we have shown them that they will not break us.”

Chicago is about to be tested on its sanctuary city status, along with New York City, Boston, Denver, and other major liberal cities.

Trump’s FCC Chair Set to Hammer Two Of The Worst Actors In Liberal Media

Two of the most influential bastions in Resistance Media are about to find out their taxpayer-funded, left-wing hit pieces do not fly with the the Trump administration.

The chairman of the Federal Communications Commission (FCC) has launched an investigation into NPR and PBS over concerns that the public broadcasters may be airing commercials in violation of federal law.

Brendan Carr, appointed by former President Donald Trump to lead the agency, sent a letter to NPR CEO Katherine Maher and PBS President and CEO Paula Kerger notifying them of the probe, according to The New York Times.

“I am concerned that NPR and PBS broadcasts could be violating federal law by airing commercials,” Carr wrote. “In particular, it is possible that NPR and PBS member stations are broadcasting underwriting announcements that cross the line into prohibited commercial advertisements.”

Public broadcasters are legally prohibited from airing traditional commercials. Instead, they rely on corporate underwriting spots, which may acknowledge sponsors but cannot explicitly encourage audiences to purchase a product or service.

“It is important to me, as Chairman of the FCC, that noncommercial educational broadcast stations stay true to their important missions and refrain from operating as noncommercial in name only,” Carr added.

In response, Maher affirmed NPR’s compliance with federal regulations, stating, “We are confident any review of our programming and underwriting practices will confirm NPR’s adherence to these rules.” PBS echoed a similar sentiment, emphasizing its commitment to “noncommercial educational programming” and stating that it “works diligently to comply with the FCC’s underwriting regulations.”

The investigation aligns with broader efforts by the former president to scrutinize public media, particularly NPR. In April, Trump took to Truth Social to declare, “NO MORE FUNDING FOR NPR, A TOTAL SCAM!” and accused the broadcaster of being “a liberal disinformation machine.”

Carr is also the author of the FCC chapter in Project 2025, a conservative policy blueprint that Trump has publicly disavowed, despite implementing several of its proposals. The chapter argues that the FCC must “change course” and prioritize policies focused on “reining in big tech, promoting national security, unleashing economic prosperity, and ensuring FCC accountability and good governance.”

Among its recommendations are requiring tech companies to contribute to the FCC’s Universal Service Fund, which subsidizes internet and connectivity programs, addressing national security concerns over TikTok, and supporting advancements in space technology, including Elon Musk’s Starlink.

FCC Commissioner Anna Gomez criticized Carr’s move, calling it “yet another administration effort to weaponize the power of the FCC.” She added, “The FCC has no business intimidating and silencing broadcast media.”

MAHA Vs The Swamp: The 5 Biggest Moments at RFK Jr’s Confirmation Hearing

Robert F. Kennedy Jr. defended his prior public statements on a range of health policy issues in a fiery confirmation hearing Wednesday.

The hearing juxtaposed a grilling from senators behind the dais and vocal supporters in the audience and in the hallway outside.

The contrast exposed a difference between how Washington, D.C., typically assesses nominees to lead the Department of Health and Human Services — a lack of controversial public statements and intricate policy knowledge — and why many in the “Make America Healthy Again” movement value Kennedy’s nomination. Kennedy supporters like his sweeping vision for change in American food and medicines and desire to challenge the status quo.

For instance, Democratic Sen. Catherine Cortez Masto of Nevada asked Kennedy about the details of a law regulating hospitals that accept Medicare payments called the Emergency Medical Treatment & Labor Act (EMTALA), showing that Kennedy did not know that the Centers for Medicare and Medicaid Services investigates violations of EMTALA.

Moments later, Kennedy emphasized his broader vision for the department: “President Trump has asked me to end the chronic disease epidemic and make America healthy again,” to applause from some in the audience.

“Democratic Senators have been trying to pin Bobby down on technicalities. RFK reminded them [of] the stakes,” said Calley Means, an advisor to Kennedy, on X. “These people are talking two different languages. It’s why we need him confirmed.”

The hearing by and large eschewed questions about Kennedy’s high-profile and controversial personal life for questions about Kennedy’s views.

The day tees up a second hearing tomorrow at the Senate Health, Energy and Labor and Pensions Committee.

While Kennedy and the MAHA movement’s popularity among Republicans has grown, his fate in the Senate is still unclear.

The Whip Count Is Still Uncertain

“It’s very clear to me some of these nominations are going to be shirts and skins,” said Republican Sen. Tom Tillis of North Carolina.

Even Democrats sympathetic to Kennedy’s critiques of the pharmaceutical industry and to his concerns about childhood obesity gave few indications they would support his nomination.

Sen. Elizabeth Warren of Massachusetts asked Kennedy about compensation received as part of his participation in lawsuits against vaccine manufacturers and asked Kennedy to drop the lawsuits or not receive compensation as a part of these actions, which Kennedy declined to commit to.

Warren begged the question of whether there was a precedent for a nominee to make money off of lawsuits against one of the entities the nominee would be regulating. By contrast, nearly every HHS secretary has received compensation from the healthcare industry.

Sen. Sheldon Whitehouse of Rhode Island was reportedly Kennedy’s roommate at University of University of Virginia School of Law. Whitehouse asked no questions. Instead he said that Kennedy should make a commitment to not say that a vaccine is unsafe if there is no evidence it is unsafe, and encouraged Kennedy to make major changes to “CMS bureaucracy.”

Republican senators who have not publicly committed to voting for Kennedy were not as animated in their lines of questioning.

Tillis expressed support for one of Kennedy’s core issues – healthier school lunches. He asked about whether Kennedy supported Operation Warp Speed, the public-private partnership to develop COVID-19 vaccines. Kennedy praised Operation Warp Speed as an achievement while emphasizing that he was supportive of Trump’s backing for non-vaccine therapeutics.

Sen. Todd Young of Indiana asked about fraud in the National Institutes of Health and trust in public health agencies.

“We need to end the good ol’ boy system and have replicable research,” Kennedy said.

Young extracted promises from Kennedy to prioritize research for novel research directions on long COVID and to continue to prioritize advancing innovation in AI and health care.

Sen. Bill Cassidy of Louisiana, the chair of the Senate HELP Committee which oversees most health policy issues, asked Kennedy about subjects outside of his typical bailiwick but relevant to the multibillion dollar programs he would oversee, including “dual eligibles” (people who are eligible for both Medicare and Medicaid), finding efficiencies in Medicaid and Medicare Advantage.

Kennedy said that he thinks most people would prefer private insurance and that the $900 billion spent on Medicaid annually is resulting in poor outcomes.

Kennedy Walked Back Some Vaccine Positions

Kennedy emphasized that he would not take dramatic action on the availability of vaccines. In a departure from prior statements, Kennedy also said he supports the measles vaccine and the polio vaccine.

“I want to empower scientists,” Kennedy said.

Ranking Member Ron Wyden of Oregon hammered Kennedy on his trip to Samoa in June 2019 amidst an outbreak of measles. Kennedy countered that the vaccination rate had already declined before his arrival, and that he encouraged better electronic health records.

“I very much like the slogan you coined, Make America Healthy Again and I very much support that effort,” said Sen. Bernie Sanders of Vermont. Sanders and Kennedy found common ground on prescription drug prices.

However Sanders grilled Kennedy about baby onesies sold by Kennedy’s former organization, Children’s Health Defense, reading “Unvaxxed Unafraid.”

The Overton Window Has Shifted On Bioweapons, Fluoride, And Food Dyes.

The hearing illustrated the degree to which Kennedy’s ascendence as a controversial figure has helped change the Overton Window on issues ranging from bioweapons, fluoride and food dyes.

Sen. Michael Bennet of Colorado asked about Kennedy’s statements about SARS-CoV-2 being a bioweapon tailored to affect some ethnic groups more than others, and that it was “highly likely” that Lyme disease resulted from an engineered bioweapon.

Concerns that COVID-19 resulted from a lab accident in Wuhan – the theory of the case favored by 69% of Americans – has contributed to increased scrutiny on lab accidents, biodefense and even bioweapons.

The ambitions of some officials in the People’s Liberation Army to develop genetically tailored bioweapons were recently highlighted in an editorial co-authored by Deputy National Security Advisor Matt Pottinger and former Biden COVID-19 response coordinator Ashish Jha.

The potential connection between fluoride in tap water and declines in IQ and the harms of unregulated food dyes in processed food, once dismissed as fringe, did not feature in Democrats’ grilling.

A September 2024 decision by the U.S. District Court for the Northern District of California ruled that fluoride in drinking water poses a risk of reduced IQ in Children.

Former President Joe Biden’s Food and Drug Administration banned red dye No. 3 in the final days of the administration, citing cancer risk, following Kennedy publicizing the issue.

Kennedy Supports Investigating Side Effects Of Medication Abortion

Democrats highlighted past statements by Kennedy, a lifelong Democrat, that diverge from the Republican Party on the issue of abortion.

Sen. Maggie Hassan of New Hampshire displayed a poster with one of Kennedy’s prior statements on abortion: “I don’t think the government has any business telling people what they can or cannot do with their body.”

Bennet questioned Kennedy about a statement on a podcast that abortion “shouldn’t be left up to the states. It should be left up to the woman.”

At Wednesday’s hearing, Kennedy said that he agrees with Trump that “every abortion is a tragedy” and that it should be left to the states.

“I came from a family that was split on choice and life.” Kennedy continued. “The good thing in my family is that we could have those conversations and respect each other.”

Republican Sen. James Lankford of Oklahoma extracted promises from Kennedy to not compel providers to provide abortion if they morally oppose it and to incentivize reporting of the adverse events of medication abortion.

Big Pharma’s Role In DC Is Under The Spotlight

The hearing has generated discussion online about the pharmaceutical industry’s influence in Washington.

Kennedy’s critics on the committee have seen their list of drugmaker donors highlighted online.

Warren’s Massachusetts houses many drug companies, including Moderna, maker of an mRNA COVID-19 vaccine.

“Speaking of shills, Senator Warren raked in over $5.2 million from Big Pharma and the medical industrial complex,” said Rep. Nancy Mace of South Carolina on X, citing data from the nonpartisan nonprofit Open Secrets.

Story by Emily Kopp of the Daily Caller News Foundation.

RFK Jr. Calls Out Senate Dems Who Rake in Big Pharma Cash

Contentious hearings to consider Robert F. Kennedy Jr. to lead the Department of Health and Human Services this week have shined a spotlight on some of Washington’s most powerful lobbies.

Senators aiming critical questions at Kennedy this week found their contributions from the health care industry and their personal investments in the pharmaceutical industry and companies that make highly processed food being spotlighted on X to millions of views. The dynamic has pitted Kennedy’s legion of online supporters against senators critical of Kennedy’s skepticism of vaccines.

At a Senate Health, Education, Labor and Pensions (HELP) Committee hearing Thursday, several senators directly addressed the popular support of the “Make America Healthy Again” movement.

Senate HELP Committee Chair Bill Cassidy of Louisiana, a Republican, was highly critical of Kennedy’s prior statements about the measles vaccine and Hepatitis B vaccine, but conceded that his phone “blows up” with his supporters.

As the hearing concluded Thursday, Cassidy said that he was struggling with whether to vote to confirm Kennedy.

“My responsibility is to learn, to try to understand if you can be trusted to support the best public health: A worthy movement called MAHA to improve the health of Americans, or to undermine it, always asking for more evidence and never accepting the evidence that is there,” Cassidy said. “That’s my dilemma, man. So you may be hearing from me over the weekend.”

Meanwhile, Kennedy and his supporters have raised questions about the corrupting influence of political contributions from the health care industry on the confirmation process.

“Our kids are getting sicker and sicker. All of the people here who are defending this current system, and defending these pharmaceutical profits, are taking huge amounts of money from the pharmaceutical industry,” Kennedy said Thursday. “This is not making our country healthier. It’s making our country sicker. We need to get rid of these conflicts.”

There has been particular scrutiny on the drugmaker money that has accrued to members of the committees that oversee many health issues — the Senate Finance Committee and the Senate HELP Committees.

The nonpartisan watchdog group OpenSecrets has tracked the top donors to the members of these committees, both their campaign committees and leadership PACs, over the past five years. The figures include both donations from individuals in each of those industries and corporate PACs. They show that, even when only considering recent election cycles, the committees have a major conflict of interest.

Senate Finance Committee Ranking Member Ron Wyden of Oregon, a Democrat, has received $749,316 from health professionals, $652,004 from insurers, $539,242 from health services and HMOs and $502,063 from the pharmaceutical industry between 2019 to 2024. His top donors include the insurers Blue Cross/Blue Shield and Centene Corporation.

Cassidy received $1,623,298 from health professionals and $996,737 from the pharmaceutical industry from 2019 to 2025, according to OpenSecrets.

Cassidy’s top donors include Ochsner Health System, a health system based in Louisiana.

Even Democrats who have been critical of the pharmaceutical industry in the past found their health care donations under scrutiny.

Sen. Elizabeth Warren of Massachusetts expressed concern Wednesday that Kennedy’s lawsuits against pharmaceutical companies could “bankrupt” vaccine manufacturers.

Warren has received $498,074 from health professionals, $126,056 from the pharmaceutical industry and $109,065 from hospitals and nursing homes over the same period. Massachusetts is home to Moderna, the manufacturer of an mRNA SARS-CoV-2 vaccine, which was just awarded a $590 million by Biden’s HHS to combat H5N1.

Sen. Bernie Sanders of Vermont, an Independent, has received $115,690 from the pharmaceutical industry and $159,233 from the food and beverage industry.

Kennedy called out Sanders’s contributions from individuals in the pharmaceutical industry during his 2020 presidential run, amounting to $1,417,633, making him a top recipient of the industry’s donations.

“The problem of corruption is not just in the federal agencies. It’s in the Congress too. Almost all the members of this panel, including yourself, are accepting millions of dollars from the pharmaceutical industry and protecting their interests,” Kennedy said.

“I ran for president like you. I got millions and millions of contributions. They did not come from the executives, not one nickel of PAC money from the pharmaceutical industry. They came from workers,” Sanders said.

Democrats and Republicans alike who are skeptical of Kennedy’s nomination have seen their donations scrutinized.

Democratic Sen. Patty Murray of Washington, the ranking member of the Senate HELP Committee, received $776,760 from the pharmaceutical industry, $674,934 from health professionals and $270,319 from health services and HMOs.

Republican Sen. Susan Collins of Maine has received $675,461 from health professionals, $426,145 from hospitals and nursing homes and $315,798 from the pharmaceutical industry.

Republican Sen. Lisa Murkowski of Alaska has received $421,580 from health professionals, $147,727 from the pharmaceutical industry, and $157,493 from the food and beverage industries.

Democratic Sen. Tim Kaine of Virginia has received $579,094 from health professionals, $452,276 from the pharmaceutical industry and $244,269 from hospitals and nursing homes.

Democratic Sen. Mark Warner of Virginia has received $379,886 from health professionals, $340,090 from hospitals and nursing homes, and $306,632 from the pharmaceutical industry.

Democratic Sen. Catherine Cortez Masto of Nevada has received $1,646,670 from health professionals, $630,475 from the pharmaceutical industry and $544,517 from health services and HMOs.

However, the influence of the health care and food and beverage industries is pervasive, and senators who support Kennedy’s nomination have received contributions from those industries too.

For instance, Republican Sen. Marsha Blackburn of Tennessee was among Washington’s top recipients of the pharmaceutical industry from 2023 to 2024.

Yet Blackburn at the Senate Finance Committee hearing Wednesday said that she strongly supported Kennedy.

“It’s time to confirm RFK Jr. as HHS Secretary. He is ready to MAHA,” she said.

In addition, recent financial disclosures show that members of the committees that oversee health issues, including Kennedy’s confirmation, have investments that could be impacted by the aims of the “Make America Health Again” movement.

A recent disclosure by Wyden shows his spouse owns stock valued at $50,000 to $100,000 in Restaurant Brands International Inc. which owns American fast food restaurant chains including Burger King, Popeyes and Firehouse Subs, and an investment worth between $15,001 to $50,000 in Starbucks. She also has an investment worth between $1,001 and $15,000 in Pfizer.

Collins’s spouse also owns a number of stocks in industries that could see new rules if Kennedy were to be confirmed, each worth between $15,000 and $50,000: EcoLab Inc.; The Hershey Company; Johnson & Johnson; Merck & Co.; and Thermo Fisher Scientific Inc.

Warner has invested between $1 million to $5 million in Health Velocity Capital I, LP, a hedge fund that invests in health care technology and between $250,000 and $500,000 in Health Velocity II, LP, venture capital fund managed by Health Velocity Capital.

Story by Emily Kopp of the Daily Caller News Foundation.

Schiff Wrecked: Kash Patel Blows Up Senate Democrat’s J6 Narrative at Hearing

FBI Director nominee Kash Patel fired back at Democratic California Sen. Adam Schiff as he spewed several allegations about his past involvement with a song sung by the “J6 Prison Choir” during his Thursday confirmation hearing.

Schiff accused Patel of being unfit to be FBI director due to his promotion of a March 2023 song recorded by the “J6 Prison Choir” titled “Justice for All,” which consisted of defendants convicted for their involvement in the January 6, 2021, Capitol riot. Patel said he had no knowledge about the defendants’ backgrounds and said he had instead “promoted the hell out of” assisting families in need.

“Isn’t that great? People who violently attack police have a number one song thanks to you, Mr. Patel. That’s something to be really proud of,” Schiff sarcastically said. “Now you claim, Mr. Patel, you didn’t know abut any of these people in the choir, is that right?”

“I did not know about the violent offenders and I did not participate in any of the violence in and around January 6,” the nominee said.

Patel, who said he did not record the song himself, released a music video for the song on Steve Bannon’s “War Room,” which included prisoners singing the National Anthem as Trump recited the Pledge of Allegiance. The song reached No. 1 on iTunes’ top songs following its release.

Patel immediately shot back at the senator as he challenged him to tell the Capitol police officers present in the room that he is proud of his promotion of the song, stating that he has always condemned violence against police officers and had worked alongside them throughout his entire career.

“I want you to turn around, there are Capitol police officers behind you. Take a look at them right now. Turn around … I want you to look at them, if you have the courage to look them in the eye, Mr. Patel, and tell them you’re proud of what you did,” Schiff said. “Tell them you’re proud that you raised money off of people who assaulted their colleagues, who pepper sprayed them, that beat them with poles. Tell them you’re proud of what you did, Mr. Patel. They’re right there, guarding you, tell them how proud you are.”

“That is an abject lie and you know it, I’ve never, never, ever accepted violence against law enforcement. I have worked with these men and women as you know my entire life and I did not make a single dime out of this,” Patel said. “How about you ask them if I have their backs and let’s see about that answer.”

Schiff stated that an FBI director should not promote songs recorded by individuals who committed violence against police officers and FBI agents. Patel repeatedly exclaimed he is fit for the position due to the years he has spent in public service.

The California senator then transitioned to asking Patel if he had made claims that Trump declassified the documents stored at Mar-a-Lago. Patel told the senator that Trump declassified “a large number” of materials that were later held in Mar-a-Lago, but did not confirm that he had done so for all the classified documents.

Trump later faced criminal charges for the alleged unlawful storage of classified materials in his residence, though Judge Aileen Cannon later dismissed the case due to its said violation of the Appointments Clause of the U.S. Constitution.

The House of Representatives voted to censure Schiff in June 2023 for falsely claiming he had evidence that Trump’s 2016 presidential campaign colluded with Russia while he served as chairman of the House Intelligence Committee. Former House Speaker Kevin McCarthy removed Schiff from the Intelligence Committee at the beginning of the 118th Congress in January 2023 over his conduct.

Story by Nicole Silverio of the Daily Caller News Foundation.

Kash Patel Demolishes Senate Democrat’s J6 Narrative

President Donald Trump’s FBI Director appointee, Kash Patel, flipped the script on Democratic Illinois Sen. Dick Durbin Thursday as he called out former President Joe Biden’s pardoning of his family members and violent criminals.

Trump signed an executive order on Jan. 20 to pardon and commute the sentences of approximately 1,500 defendants charged for their actions at the Jan. 6, 2021, Capitol riot. At Patel’s confirmation hearing, Durbin asked the nominee whether he opposed the blanket pardons for the defendants after pointing to an egregious example of one of the individual’s violent actions after being released from prison.

“Was President Donald Trump wrong to give blanket clemency to the January 6 defendants?” Durbin asked.

“Thank you ranking member, a couple of things on that,” Patel said. “One, the power of the presidential pardon is just that, the president … as we discussed in our private meeting senator, I have always rejected any violence against law enforcement and including in that group, [I have] specifically addressed any violence against law enforcement on January 6 and I do not agree with the commutation of any sentence of any individual who committed violence against law enforcement.”

Durbin then asked the nominee if he believes the U.S. is “safer” as a result of the commutations, leading Patel to point to Biden’s last-minute commutation of Native American activist Leonard Peltier who served a life sentence for the deaths of two FBI agents in June 1975. The now-former president commuted the sentences of 2,500 individuals, including two who were convicted of killing a police officer, on the Friday before he left office.

“Senator, I have not looked at all 1,600 cases, I have always advocated for imprisoning those who cause harm to our law enforcement and civilian communities. I also believe America is not safer because [of] President Biden’s commutation of a man who murdered two FBI agents. Agent Coler’s and Agent William’s family deserve better than to have the man who at point-blank range, fired a shotgun into their heads and murdered them released from prison. So it goes both ways,” Patel said.

Durbin attempted to defend Biden’s commutations by arguing that Peltier is an elderly man who is in home confinement. When he continued to press Patel on the pardoned defendants, the FBI nominee said the nation will be safe once the number of homicides and drug overdoses is reduced across the U.S.

Biden pardoned his son, Hunter, in December of any crimes potentially committed between Jan. 1, 2014 and Dec. 1, 2024, and issued preemptive pardons for five of his family members minutes before he exited office. Durbin criticized the former president for issuing the last-minute pardons for his family during a Jan. 21 appearance on CNN.

Story by Nicole Silverio of the Daily Caller News Foundation.

JUST IN: Democratic Party Approval Crashes to All-Time Low in New Polling

The Democratic Party’s approval rating is nearing an all time low, according to the results of Quinnipiac polling released Wednesday.

Just 31% of registered voters approve of the Democratic Party, the lowest favorability rating the pollster has recorded of the party since it began asking the question in 2008. The Democratic Party’s near-historic low favorability rating follows an election cycle during which Democrats nominated an unpopular presidential candidate to replace Biden after party elites and the corporate media colluded to conceal the former president’s cognitive decline from the American people.

Nearly six in ten Americans disapprove of the Democratic Party’s brand, according to the Quinnipiac poll.

Biden and former Vice President Kamala Harris, who was selected to replace Biden at the top of the Democratic ticket in 2024, both left office in January with favorability ratings underwater. The former president departed from Washington with the lowest approval rating of any president on record, according to CNN’s Harry Enten.

Americans across the political spectrum, including some Democratic lawmakers, torched the Biden’s unprecedented use of the pardon power during his final weeks in office. The former president pardoned members of his family, controversial government officials and a convicted cop killer, in the last weeks of his term.

“The decision was appalling,” Democratic Connecticut Sen. Richard Blumenthal told Fox News’ Sunday on Jan. 26 regarding Biden’s decision to grant clemency to a man convicted of murdering an eight year-old boy and his mother.

Increasingly poor perception of the Democratic Party’s brand also follows the departure of two former Democratic senators, Joe Manchin of West Virginia and Kyrsten Sinema of Arizona, from the party in recent years after both repeatedly clashed with left-wing Democratic lawmakers over Biden’s legislative agenda.

“The D brand has been so maligned from the standpoint of, it’s just, it’s toxic,” Manchin told CNN last December. Manchin left the Democratic Party in May 2024 amid public speculation he was considering a future gubernatorial or presidential run.

Many Democrats have struggled to understand how they lost the popular vote for the first time since 2004 and shed four Senate seats in November, giving the GOP a governing trifecta for the first time in eight years.

The Democratic Party is also heading into President Trump’s second term without a clear leader of the party.

“I think Democrats are in the wilderness,” MSNBC’s Jen Psaki said in November following President Donald Trump’s decisive victory.

Support for the Republican Party, in sharp contrast, is at a record high with 43% of registered voters holding a favorable view of the GOP, according to the poll.

Speaker Mike Johnson reportedly said Tuesday that he believes House Republicans will be able to hold their majority for the next decade.

The Republican Party’s 12% higher approval rating over the Democratic Party is the largest favorability advantage Quinnipiac has recorded of the GOP over the Democratic Party since its university poll began asking registered voters about their views on America’s political parties, according to background Quinnipiac released on the poll.

Trump’s approval rating is currently 46%, which is ten points higher than when the president was sworn into the Oval Office in January 2017, according to the poll results.

The polling surveyed 1,019 self-identified registered voters from Jan. 23-27 and has a margin of error of roughly 3%.

The Democratic National Convention did not immediately respond to the Daily Caller News Foundation’s inquiry regarding its approval rating.

Story by Adam Pack of the Daily Caller News Foundation.

Donald Trump Delivers Bad News to Canadian PM Trudeau at Mar-a-Lago

Donald Trump invited Canadian Prime Minister Justin Trudeau to Mar-a-Lago to have dinner with him on Friday evening.

While Trudeau was at the presidential home, Trump delivered bad news that told him loud and clear: The days of Canada and Mexico taking advantage of America are over.”

Trump has proposed a 25% tariff on goods from Canada and Mexico, tying the measure to his pledge to curb the flow of drugs and migrants across U.S. borders. Trudeau has signaled already that he is willing to help stem the flow of fentanyl across the northern border.

The president-elect indicated the tariffs would be among his first executive actions upon taking office in January. While Trump’s team did not elaborate on the dinner discussion, Trudeau commented briefly, characterizing the exchange as constructive.

The stakes of the meeting were high, especially given past tensions between the two leaders. Trump has previously referred to Trudeau as “weak” and “dishonest,” yet the Canadian prime minister was the first G7 leader to meet with Trump following his November 5 election.

Daniel Béland, a political science professor at McGill University, suggested the move was calculated, saying, “Tariffs are a crucial issue for Canada, and a bold move was in order. Perhaps it was a risk, but a risk worth taking.”

Canadian Prime Minister Justin Trudeau nonetheless described his meeting with President-elect Donald Trump at the Mar-a-Lago club as an “excellent conversation,” according to The Washington Times. The meeting followed Trump’s threats to impose significant tariffs on Canada and Mexico, causing concern in Ottawa and Mexico City.

As Trudeau returned to Canada from Florida, it remained unclear whether the discussion had alleviated Trump’s concerns. A source familiar with the three-hour dinner, speaking on condition of anonymity, called it “positive and wide-ranging.” Topics reportedly included trade, border security, fentanyl, defense, NATO, Ukraine, China, the Middle East, pipelines, and the upcoming Group of Seven (G7) meeting in Canada, according to the Washington Times.

The dinner included key figures from both governments. Among the attendees were Trump’s nominees for commerce secretary, Howard Lutnick, and national security adviser, Mike Waltz. Trudeau was joined by Public Safety Minister Dominic LeBlanc and Chief of Staff Katie Telford.

Ahead of the meeting, Trudeau expressed optimism about resolving the tariff issue through dialogue. He also highlighted the potential consequences of such measures, warning that they could harm Canadian and U.S. industries alike by driving up prices and disrupting trade.

Experts have pointed out that new tariffs could jeopardize the recently renegotiated North American free trade agreement, which Trudeau has described as a “win-win” for both nations. Nelson Wiseman, professor emeritus at the University of Toronto, observed that Trump likely understands the economic risks but continues to use the tariff threats to project strength.

“His goal is to project the image that he gets action when he talks,” Wiseman said.

Trump has linked his tariff threats to broader concerns about migration and fentanyl. While he cited the Canadian border in his remarks, evidence suggests that the scale of these issues is far smaller compared to the U.S.-Mexico border. Canadian officials have pushed back against being grouped with Mexico in Trump’s rhetoric, while affirming their readiness to bolster border security.

Canada remains the largest export market for 36 U.S. states, with approximately $2.7 billion worth of goods and services crossing the border daily. During Trump’s first term, his administration imposed tariffs on Canadian steel and aluminum, prompting retaliatory duties from Canada.

Donald Trump is setting the tone that America will reassert itself on the global stage. This vision entails leveraging the United States economic clout and market power to renegotiate trade deals that promote the national interest.

Big Pharma Melts Down After RFK Jr. Calls to Ban Drug Advertising

President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to helm the Department of Health and Human Services(HHS) is reportedly rattling drugmakers in light of Kennedy’s prior calls to ban pharmaceutical advertising.

If confirmed by the Senate to serve as HHS secretary, Kennedy could marshal the country’s public health agencies to implement his Make America Healthy Again (MAHA) priorities, leading one pharmaceutical industry observer to claim that Kennedy is likely to attempt a ban on direct-to-consumer (DTC) drug advertising. However, any attempt from Kennedy to crack down on pharmaceutical advertising would almost certainly be challenged by drugmakers on First Amendment grounds and may lack the support of Trump and Republican lawmakers who have so far refrained from commenting on Kennedy’s proposal.

“One of the things I’m going to advise Donald Trump to do in order to correct the chronic disease epidemic is to ban pharmaceutical advertising on TV,” Kennedy said to thunderous applause during a Tucker Carlson Live Tour event in Glendale, Arizona, on Oct. 31. “There’s only two countries in the world that allow pharmaceutical advertising on the airwaves. One of them is New Zealand and the other is us and we have the highest disease rate, and we buy more drugs and they’re more expensive than anywhere in the world.”

Spending on DTC pharmaceutical advertising in the United States ballooned to more than $7 billion in 2023, with ad buys on weight loss and diabetes drugs surpassing $1 billion for the first time, according to analysis from MediaRadar.

‘Threat To The Public Good’ 

“Whilst we have a relatively benign view of RFK’s impact on the Pharma industry, one thing that does worry us is the potential for the U.S. government to ban DTC advertising of drugs,” United Kingdom-based research firm Intron Health wrote in a report excerpted by FiercePharma, a pharmaceutical industry-focused news outlet. “We see this as the biggest imminent threat from RFK and the new Trump administration.”

Kennedy could wield considerable influence over the second Trump administration’s approach to pharmaceutical advertising since the Food and Drug Administration (FDA) — the chief regulator of the pharmaceutical industry’s advertisements — is housed within HHS.

The Biden FDA issued new guidelines on DTC advertising that went into effect on May 20, requiring advertising to state drugs’ side effects and medication risks in a “clear, conspicuous, and neutral manner.” Kennedy called for a review of these guidelines in an op-ed in The Wall Street Journal published on Sept. 5.

During his run for president and as a Trump campaign surrogate, Kennedy claimed that media outlets who receive substantial ad revenue from pharmaceutical companies cannot report on Big Pharma with objectivity.

“The primary purpose of pharmaceutical advertising is not to influence consumers, but rather the television networks and news itself,” according to a statement on Kennedy’s website. “It gives Big Pharma the power to dictate what goes on the news — and what doesn’t — because the networks won’t bite the hand that feeds them.”

“Every other country in the world recognizes that pharma ads represent a threat to the public good,” Kennedy’s website also claims.

Kennedy’s concern that mainstream media has been co-opted by the pharmaceutical industry to buy news outlets’ silence on scrutinizing drugmakers in exchange for ad revenue has been embraced by influential voices in the MAHA movement and other Trump allies.

“The news ad spending from pharma is a public relations lobbying tactic, essentially to buy off the news,” Calley Means, a Kennedy advisor and MAHA advocate, told Tucker Carlson during an interview on Feb 2. “The news is not investigating pharma.”

“No advertising for pharma,” Elon Musk wrote on X on Nov. 19 in response to a post alleging a correlation between the growth of pharmaceutical advertising and rising media bias.

Dr. Jay Bhattacharya, Trump’s nominee to lead the National Institutes of Health, has also argued that media organizations that rake in pharmaceutical advertising revenue should face increased scrutiny when reporting on public health matters. Bhattacharya was notably blacklisted by Twitter before Musk bought the platform over his criticism of the medical establishment’s lockdown approach to the COVID-19 pandemic.

“Another argument against direct-to-consumer advertising by drug companies: Because of DTC ads, drug companies like Pfizer hold a vice grip on the editorial policies of conventional American media, which can ill afford to lose the advertising money,” Bhattacharya wrote on X on May 30, 2023.

Dr. Marty Mackary, Trump’s pick to lead the FDA, has not commented on Kennedy’s proposal nor allegations that the mainstream media has been corrupted by the pharmaceutical industry.

Ban Denies ‘Opportunity To Be Informed’

Although a ban on pharmaceutical advertising would put the U.S. more in line with the rest of the world, an attempted prohibition of the practice by the incoming Trump administration would likely infringe upon the First Amendment’s protection of “commercial speech,” according to Dr. Jeffrey Singer, a general surgeon and senior fellow at the libertarian-leaning Cato Institute.

“His calls to ban pharmaceutical advertising violate the First Amendment right to freely share and exchange information, including scientific information, and infringe on the individual right to self-medicate,” Singer wrote in a statement following Trump’s nomination of Kennedy to serve as HHS secretary.

Banning pharmaceutical advertising would also make Americans less informed about the availability of drugs and their side effects and widen the information gap between medical practitioners and patients, an apparent contradiction to Kennedy’s pledge to fight for Americans’ ability to question the medical establishment and do their own research, Singer told the Daily Caller News Foundation in an interview. (RELATED: Americans Sour On Big Pharma After Pandemic, Opioid Crisis: POLL)

“On the one hand, RFK Jr. says — and I agree with him — that people need to be empowered. They need to do their own due diligence. We should be doing our own investigations,” Singer told the DCNF. “Well, how are you going to do that if you are barred from hearing what the pharmaceutical companies have to say about their medication, and its risks and benefits and side effects, which the FDA requires them to mention?”

“If you want an empowered population of adults to be able to do their own due diligence, you can’t block them from the information that a pharmaceutical [ad] is going to give them — especially when they’re [pharmaceutical companies] allowed to give it to healthcare practitioners,” Singer added. “Denying us the information actually denies us the opportunity to be informed.”

Uncertain Political Prospects

Kennedy’s call to ban pharmaceutical advertising is likely to face skepticism from Republican lawmakers who have traditionally preferred a deregulatory approach to the pharmaceutical industry. The current legislative effort to ban DTC pharmaceutical advertising in Congress has no support from Republican lawmakers. (RELATED: ‘It Doesn’t Affect Me’: Trump Reveals Who Wasn’t ‘Thrilled’ About His Team Up With RFK Jr.)

“Sometimes when I hear his [Kennedy’s] agenda discussed, people are like ‘sounds great — he’s never going to do it’. There’s zero chance he’s going to be able to undo these conflicts of interests and the power of Big Ag and these Republican lawmakers who have a lot of big donors in these industries,” Megyn Kelly told Casey Means, during a Nov. 20 interview on her show about whether Kennedy’s MAHA priorities have enough support to be achieved during the next four years.

The pharmaceutical industry notably has roughly 1800 registered lobbyists in the United States, and industry PACs have doled out more than $15 million to candidates this year.

Trump tried to further regulate pharmaceutical advertising during his first administration by requiring DTC ads on television to include the list price for nearly all drugs covered by Medicare and Medicaid. Three large drugmakers filed suit in response and a federal judge struck down the regulation before it went into effect, ruling that HHS overstepped its authority to compel drugmakers to include their list prices in advertising.

Trump’s transition team did not respond to the DCNF’s inquiry about whether the president-elect supports Kennedy’s advocacy to crack down on pharmaceutical advertising.

The Pharmaceutical Research and Manufacturers of America, a trade association that lobbies on behalf of the pharmaceutical industry, declined to comment on Kennedy’s calls to ban pharmaceutical advertising.

A Kennedy spokesperson did not respond to the DCNF’s request for comment.

Syndicated from the Daily Caller News Foundation.

Jack Smith Could Face ‘Severe Consequences’ For Election Interference Against Trump

Special counsel Jack Smith may not be in the clear, even after dropping all charges against President-elect Donald Trump.

Smith’s decision to dismiss his cases against Trump on Monday reignited calls for an investigation into his efforts. While it’s unclear if probing Smith is high enough on Trump’s priority list to translate talk into action, some aren’t ready to simply brush Smith’s months-long pursuit aside now that the threat is gone.

Investigating the federal prosecutions against Trump is important “because of the huge cost and ultimate failure,” former federal prosecutor Andrew Cherkasky told the Daily Caller News Foundation.

“Whether that yields findings of criminality is unlikely. However, I think it will find that Smith’s novel legal approach was fraught with issues that should have led a reasonable prosecutor to decline prosecution,” Cherkasky told the DCNF. “Smith is already leaving his special counsel post, but I anticipate some of the lawyers working under him will also be forced out of the [Department of Justice] DOJ for engaging in a legally unsound prosecution.”

Smith’s two Trump prosecutions cost taxpayers upwards of $50 millionaccording to DOJ reports.

“There is a lot of evidence that the congressional Jan. 6 committee intentionally avoided evidence beneficial to Trump’s position, and if Smith did the same, his conduct could be grounds for more severe consequences,” Cherkasky noted.

The Heritage Oversight Project posted on X Monday that they are preparing a “model indictment” of Smith. Executive Director Mike Howell suggested Smith could be charged under the federal law prohibiting a conspiracy to violate an individual’s civil rights, but told the DCNF there are “other potential avenues as well.”

“Jack Smith and his office must face severe legal, political, and financial consequences for their blatant lawfare and election interference,” Article III Project President Mike Davis like wrote Monday on X. “This includes a federal criminal probe for conspiracy against rights under 18 U.S.C. § 241.”

One of Smith’s charges against Trump was brought under the same conspiracy against rights statute.

Charles Stimson, deputy director of the Heritage Foundation’s Edwin Meese III Center for Legal and Judicial Studies, pointed out that Trump didn’t use his first term to go after Hillary Clinton or those involved in the Russia collusion narrative. “Past is prologue here,” he told the DCNF.

Trump’s attorney general pick Pam Bondi will have other pressing issues to focus on, such as illegal migrants who committed crimes in the U.S. and protecting free speech, Stimson said. She probably won’t be looking into the past, especially when government employees, including prosecutors like Smith, have immunity for actions taken within their job.

“I don’t think they’re going to spend a tremendous amount of time deciding whether Jack Smith, who will not be employed by the Justice Department, should be prosecuted,” Stimson said.

It’s also possible Congress will take up the cause of investigating Smith.

House Judiciary Committee Chair Jim Jordan, along with Republican Georgia Rep. Barry Loudermilk, told Smith’s team in a Nov. 8 letter to preserve all records related to the Trump prosecutions. Republican senators Chuck Grassley of Iowa and Ron Johnson of Wisconsin letter also put Smith on notice to preserve records.

“Due to the apparent political bias of FBI officials that were involved in the genesis of a case against former President Trump, preservation of Special Counsel Smith’s records is more important than ever,” Grassley and Johnson wrote in the Nov. 13 letter. “If a politically-charged case is to be opened, it must be done the right way and free from political bias.”

Syndicated from the Daily Caller News Foundation.